Created for Mediaplanet
This article was made possible with support from ModernaTx
Messenger ribonucleic acid (mRNA) is a code-carrying molecule that instructs your body to make proteins. Some proteins can treat or protect against a disease.
For over a decade, Moderna has been investigating the potential of its mRNA platform to address unmet needs in multiple therapeutic areas. This pioneering work has earned Moderna the reputation of being at the forefront of mRNA science.
Building on this experience and expertise ? and recent, real-world success of its COVID-19 vaccine rollout ? Moderna is rapidly developing a new class of vaccines and medicines against current and emerging diseases. ?Our mRNA platform has the potential to transform multiple facets of medicine going forward,? says Dr. Shehzad Iqbal, Country Director, Moderna Canada. Dr. Shehzad Iqbal, Country Medical Director, Moderna Canada
In addition to fighting COVID-19 and its emerging variants, Moderna is researching new mRNA vaccines against other diseases like cytomegalovirus (CMV), respiratory syncytial virus (RSV), and the flu. ?mRNA has the potential to prevent diseases in a completely different way, and offer potential new ways of treating them,? says Iqbal.

Rapid vaccine development possible thanks to simplified process
Our cells use mRNA to make proteins every minute of the day for every single function our bodies perform. ?There are millions of these different kinds of proteins and mRNA is the code for bui...